ROTAVAC

Bharat Biotech

ROTAVAC Contact Solution Provider

Solution Overview & Benefits

ROTAVAC® India’s first indigenously developed Rotavirus Vaccine. The vaccine will be sold to global public markets, Governments worldwide including UN procurement agencies at a price of US $ 1. Bharat Biotech hopes its new vaccine will help prevent part of the ~ 500,000 child deaths each year caused due to rotavirus diarrhea and improve access to better, affordable rotavirus vaccines.

History & Development

Rotavirus is the top cause of deadly diarrhea in developing countries. ROTAVAC® was developed by a cross-sector partnership led by the Government of India.

Availability

Publicly available: yes
Countries where available: India
Price range (USD): 1 to 20 USD

Additional Information

 
Solution Providers Website (external link) Product Webpage (external link)

Updates

If you are aware of any updates to the ROTAVAC project please complete the form or send an email to [email protected]

Need help finding solutions that respond to your unique development challenges? Apply through our Project Accelerator service or Contact us directly for needs-based project consulting.